RecruitingNot ApplicableNCT06307574

bpMedManage: Digital Technology to Support Adherence to Hypertension Medications

Digital Technology to Support Adherence to Hypertension Medications for Older Adults With Mild Cognitive Impairment

Sponsor

University of Arizona

Enrollment

100 participants

Start Date

Feb 29, 2024

Study Type

INTERVENTIONAL

Conditions

Hypertension Aging Mild Cognitive Impairment

Summary

The purpose of the bpMedManage study is to rigorously test the efficacy of a smartphone technology to help improve high blood pressure medication adherence among older adults with mild cognitive impairment (MCI) in a 16-week randomized controlled trial. A total of 100 older adults will be recruited. There will be two treatment arms, bpMedManage-S and bpMedManage-P with 50 participants in each arm. Participants randomized into the bpMEDManage-S intervention arm will use a smartphone application with medication reminders plus receive education with standardized information on hypertension and antihypertensive medications on the education portal. Participants in the bpMedManage-P group will use a smartphone to receive education with standardized information on hypertension and antihypertensive medications on an education portal. Both groups will complete baseline assessments followed by 4 weeks of medication adherence monitoring. At the end of the adherence monitoring period, participants will be randomized into one of the two treatment arms. Immediate outcomes on primary and secondary measures will be assessed 4 weeks after beginning of the intervention. Follow-up outcomes will be assessed 12 weeks after the beginning of the intervention.

Eligibility

Min Age: 60 Years

Inclusion Criteria11

Age 60+
Community-dwelling older adults
Self-reported fluent in English
Adequate self-reported visual and hearing ability
Self-reported memory, thinking, or concentration challenges
Self-manage at least one prescribed antihypertensive medication
Have and use a smartphone
No self-reported history of major depression or other mental health diagnoses
No self-reported diagnosis of dementia or other neurological disorder such as stroke, TBI, and Parkinson's disease
TICS-M score between 27-37 and Montreal Cognitive Assessment (MoCA) score between 20-26
Willing to participate in the study for at least 4 months

Exclusion Criteria2

Diagnosis of dementia
Lives in assisted living facility or skilled nursing facility

Interventions

BEHAVIORALbpMedManage

In this 16-week RCT, a total of 100 older adults with MCI will be recruited. There are two treatment arms, bpMedManage-S and bpMedManage-P with 50 participants in each arm. Participants randomized into the bpMEDManage-S intervention arm will use a smartphone application with medication reminders plus receive education with standardized information on hypertension and antihypertensive medications on the education portal. Participants in the bpMedManage-P group will use a smartphone to receive education with standardized information on hypertension and antihypertensive medications on the education portal. Both groups will complete baseline assessments followed by 4 weeks of medication adherence monitoring. At the end of the adherence monitoring period, participants will be randomized into one of the two treatment arms. Immediate outcomes will be assessed 4 weeks after beginning of the intervention. Follow-up outcomes will be assessed 12 weeks after the beginning of the intervention.